HOME >> BIOLOGY >> NEWS
Sea Grant study finds Chinese mitten crabs appear free of human parasite lung flukes

nvasive nuisance species elsewhere. The crabs were first identified in California in 1992, after a shrimp trawler working the South San Francisco Bay hauled up a strange looking crab with fuzzy claws.

However, the crab most likely was introduced to San Francisco South Bay much earlier, in the late 1980s. A hearty and fecund invader, the crab has multiplied to such numbers that it now overruns parts of the bay. In 1998, state workers hauled away about 50 tons worth of mitten crabs that had clogged fish screens at state water pumps near Tracy. Besides clogging fish salvage tanks, mitten crab burrows undermine banks and levees, accelerating erosion and unwanted slumping.

To date, there are no strategies in place for controlling the crab's numbers. Fishers are suggesting that the crab population be culled by opening the mitten crab to commercial fishing, but this is problematic, too.

Dugan said, "The idea is to figure out a way to get rid of the crabs. If you open a fishery, suddenly, they have a value."

Another concern is that parasites could spread like fire in a hayloft through the bay at some later date, because of the sheer number of crabs. Not just people but also raccoons and other animals that feed on mitten crabs could be infected.

Because crayfish are a potential intermediate host for the flukes, the scientists also dissected more than 400 crayfish from the estuary. Like the crabs, all the crayfish appear free of lung flukes.

Despite their findings, the scientists are cautious about concluding that eating the crabs is safe now or in the future.

"Until we finish our survey of the region's snails," Walter said, "we can't assess the risk of future introductions of lung flukes."

The scientists are in the process of analyzing hundreds of freshwater snails from the area to look for evidence of lung flukes. Even if the snails turn up clean, Culver said, there are other major health concerns - such as b
'"/>

Contact: Carrie Culver
c_culver@lifesci.ucsb.edu
805-893-8093
National Sea Grant College Program
14-Nov-2001


Page: 1 2 3

Related biology news :

1. Grant advances biochemical engineering laboratory
2. GlaxoSmithKline Drug Discovery and Development Research Grant Program 2004
3. Grant from GE Foundation to University of Houston to strengthen math, tech pipeline
4. McGill Centre for Intellectual Property Policy receives $3 million SSHRC Grant
5. Grant promotes marine ornamental fish aquaculture
6. Grant of powerful computer to Rutgers-Newark will increase understanding of brain activity
7. Grant renews funding of research toward cloning primates
8. Lipids get the spotlight in new NIGMS Glue Grant
9. Grant funds research to develop tissue-engineered solutions for heart disease
10. Grant strengthens research arm of Penn State Hershey Medical Centers ALS Clinic
11. Sea Grant News & Notes for March 26, 2003

Post Your Comments:
(Date:5/20/2013)... resistant to the antibiotic colistin are also commonly ... body, according to a study in mBio ... Society for Microbiology. Cross-resistance to colistin and host ... body against bacterial attack, could mean that patients ... with a crippled immune response. Colistin is a ...
(Date:5/20/2013)... Science Foundation (NSF) planning grant will help establish the ... program of the University of Illinois at Urbana-Champaign and ... will be devoted to research in drying moist, porous ... and paper products; chemical products; textiles; and biopharmaceuticals," said ... science and human nutrition and the Illinois site director. ...
(Date:5/19/2013)... strain of electricity-producing bacteria that can grow using hydrogen ... as its sole source of carbon. Researchers at ... the 113th General Meeting of the American Society for ... production solely on hydrogen," says Amit Kumar, a researcher ... part of the Lovley Lab Group at the university. ...
Breaking Biology News(10 mins):Resistance to last-line antibiotic makes bacteria resistant to immune system 2Resistance to last-line antibiotic makes bacteria resistant to immune system 3NSF approves planning grant for Center for Advanced Research in Drying 2
(Date:5/21/2013)... Raleigh, NC (PRWEB) May 21, 2013 ... and financial services company for clinical trials, announced ... Aggregate Spend Solutions, LLC. Clinverse’s ClinPay® FLS ... automated investigator payment process. SpendMD ™, ... only complete solution for tracking and reporting transfer ...
(Date:5/21/2013)... , May 21, 2013 According ... Research ( http://www.transparencymarketresearch.com ) "Biochip Products and Services Market ... - U.S. Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," ... 2011 and is expected to grow at a CAGR ... estimated value of USD 4.7 billion in 2018. ...
(Date:5/21/2013)... 21, 2013 Many have long discussed ... to acne. Recently physicians from Clinical Psychiatry.com ... on the skin, and suggested using hypnotherapy ... chemicals produced from stress that cause acne. , Doctors ... feelings acne brings about, stress causes changes in the ...
(Date:5/21/2013)... ROCKVILLE, Md. , May 21, 2013 /PRNewswire/ ... "Phase 1 study of margetuximab (MGAH22), an Fc-modified ... solid tumors expressing the HER2 oncoprotein," will be ... American Society of Clinical Oncology during the Developmental ... June 3 at 4:15 – 4:30 PM.  The ...
Breaking Biology Technology:Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 2The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 4The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 5Adult Acne Treatment, Probiotic Action Explains How Hypnotherapy and Probiotics May Cure Various Skin Conditions 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3
Cached News: